Jeff Aronin discusses why Paragon Biosciences’ unique company incubator approach results in an 80%–90% approval rate on new drug applications, far exceeding that of the traditional pharma industry. Read more about Jeff Aronin’s take on… Read more
Chicago is in the midst of a biotech influx, with expansive lab space planned for development. The recent growth can be largely attributed to a year focused on science and medical advancement due to the… Read more
Evozyne, a portfolio company of Paragon Biosciences, announced that a peer-reviewed publication in the journal Science demonstrates successful use of its world-class molecular engineering technology to create never-before-seen proteins with exceptionally advanced functionality. The Chicago-based… Read more
Jeff Aronin, who is the founder, chairman and CEO of Paragon Biosciences, spoke with Chief Executive about why healthcare is stagnant from an innovation standpoint, the importance in doing meaningful work and more. Read about Jeff Aronin’s… Read more
CHICAGO–(BUSINESS WIRE)–Paragon Biosciences Chairman and CEO Jeffrey S. Aronin won a 2019 BIG Innovation Award presented by the Business Intelligence Group. The award honors executives whose leadership improves quality of life. Read the full article… Read more
CHICAGO–(BUSINESS WIRE)– Jeff Aronin, Chairman and CEO of Paragon Biosciences, was named 2018’s Innovator of the Year by Best in Biz Awards for his lifelong work towards developing treatments for severe medical conditions. The award… Read more
Jeff Aronin can pinpoint the moment his personal journey in medicine began. Jeff, now the Chairman and CEO of Paragon Biosciences, was working for a company that had developed medication for seizure disorders. To learn… Read more
The Midwest Region hosted a memorable Gala Dinner under the theme of “Breakthrough: Celebrating Discoveries. Shaping Tomorrow.” More than 500 community and industry leaders came together at the Fairmont Chicago Millennium Park to honor Jeffrey… Read more